Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
HOMRE Ltd (NSE: HOM), ISIN INE982C01033 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
HOM last traded at ₹1.76 (-0.56%), with a 52-week range of ₹1.15 to ₹3.47 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 64.03%, FIIs 0.23%, DIIs 0.10%, mutual funds 0.10%.
EquiSense Score (ECS): 52/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.